Adaptive Biotechnologies Corp expected to post a loss of 42 cents a share - Earnings Preview

Adaptive Biotechnologies

02/11/2021 02:08

* Adaptive Biotechnologies Corp  ADPT.OQ   ADPT.O  is expected
to show a rise in quarterly revenue when it reports  results on
November 3. 
* The Seattle, Washington-based company is expected to report  a
39.3% increase in revenue to $36.636 million from $26.3 million
a year ago, according to the mean estimate from 7 analysts,
based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Adaptive
Biotechnologies Corp is for a loss of 42 cents per share. For
the same quarter last year, the company reported a loss of 27
cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Adaptive
Biotechnologies Corp is $54​, about 34.6% above​ its last
closing price of $35.34. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 302021   -0.42       -0.43      -0.35     Beat    18.1
 Mar. 312021   -0.41       -0.41      -0.29     Beat    29
 Dec. 312020   -0.29       -0.29      -0.33     Missed  -12.7​
 Sep. 302020   -0.29       -0.28      -0.27     Beat    5
 ​​Jun.        -0.32       -0.28      -0.26     Beat    8.8
 302020                                                 
 Mar. 312020   -0.20       -0.20      -0.25     Missed  -22.2​
 Dec. 312019   -0.19       -0.20      -0.17     Beat    14.1
 Sep. 302019   -0.23       -0.24      -0.11     Beat    53.5
 This summary was machine generated November 2 at 02:08 GMT.  All
figures in US dollars unless otherwise stated